QR Code

Efficacy and safety of perioperative sintilimab plus platinum-based chemotherapy for potentially resectable stage IIIB non-small cell lung cancer (periSCOPE): an open-label, single-arm, phase II trialResearch in context

Summary: Background: The absolute overall survival (OS) improvement with preoperative chemotherapy or chemoradiotherapy in locally advanced non-small cell lung cancer (NSCLC) patients is controversial and unsatisfactory. We designed this trial to explore the efficacy and safety of perioperative sin...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Xiangyang Yu, Chujian Huang, Longde Du, Chunguang Wang, Yikun Yang, Xin Yu, Shengcheng Lin, Chenglin Yang, Hongbo Zhao, Songhua Cai, Zhe Wang, Lixu Wang, Xiaotong Guo, Baihua Zhang, Zhentao Yu, Jie He, Kai Ma
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Elsevier 2025-01-01
Rangatū:EClinicalMedicine
Ngā marau:
Perioperative chemoimmunotherapy
Potentially resectable
IIIB
Non-small cell lung cancer
Sintilimab
Urunga tuihono:http://www.sciencedirect.com/science/article/pii/S2589537024005765
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite